|
WDR43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71220038147624E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61469999593322E-08 |
| Normal-vs-Stage2 |
2.39449999994701E-06 |
| Normal-vs-Stage3 |
2.54190002380028E-09 |
| Normal-vs-Stage4 |
3.4066971466018E-11 |
| Stage1-vs-Stage2 |
6.508600E-01 |
| Stage1-vs-Stage3 |
2.175600E-01 |
| Stage1-vs-Stage4 |
1.394280E-02 |
| Stage2-vs-Stage3 |
6.837800E-01 |
| Stage2-vs-Stage4 |
2.025400E-01 |
| Stage3-vs-Stage4 |
2.533800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91609991498865E-10 |
| Normal-vs-AfricanAmerican |
5.223400E-04 |
| Normal-vs-Asian |
4.45299999984883E-07 |
| Caucasian-vs-AfricanAmerican |
5.658800E-01 |
| Caucasian-vs-Asian |
9.727600E-01 |
| AfricanAmerican-vs-Asian |
5.798800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78089987201702E-10 |
| Normal-vs-Female |
2.27289997933866E-09 |
| Male-vs-Female |
2.438200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98669999954093E-07 |
| Normal-vs-Age(41-60Yrs) |
1.9260004702204E-10 |
| Normal-vs-Age(61-80Yrs) |
6.42660036298537E-10 |
| Normal-vs-Age(81-100Yrs) |
2.900800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.422400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.287430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.085000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.667000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.731000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.588000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.338160E-01 |
| Classical-VS-Follicular |
1.195760E-02 |
| Classical-VS-Other |
3.513400E-01 |
| Classical-VS-Normal |
5.83379999863354E-08 |
| Tall-VS-Follicular |
8.865600E-01 |
| Tall-VS-Other |
8.711000E-01 |
| Tall-VS-Normal |
6.942600000448E-07 |
| Follicular-VS-Other |
9.453000E-01 |
| Follicular-VS-Normal |
3.49749995631754E-09 |
| Other-VS-Normal |
2.635300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.79669970410157E-10 |
| Normal-vs-N1 |
2.17779999589496E-08 |
| N0-vs-N1 |
7.233600E-01 |
|
|
